Evidence map›Paper›PMID 40959297›Full record

ArticleRSC advances2025

Chiral binaphthol-catalyzed enantioselective conjugate addition of alkenyl trifluoroborate salts to alkenyl-substituted benzothiazoles.

Wei-Yu Huang, Yang-Ling Wang, Cai-Guang Li, Kangbao Zhong, Gongming Zhu, Junbiao Chang, Guo-Li Chai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei-Yu HuangState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Yang-Ling WangState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Cai-Guang LiState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Kangbao ZhongState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Gongming ZhuState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Junbiao ChangState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.
Guo-Li ChaiState Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, School of Chemistry and Chemical Engineering, Henan Normal University Xinxiang Henan 453007 China zhongkangbao@htu.edu.cn guolichai@126.com.ORCID https://orcid.org/0000-0002-1342-6217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chiral binaphthol-catalyzed enantioselective conjugate addition of alkenyl trifluoroborate salts to alkenyl-substituted benzothiazoles is reported, providing the 1,4-addition products in moderate to high yields and excellent enantioselectivities (up to >99% ee). This scalable catalytic system exhibits high efficiency and broad substrate scopes. Additionally, alkenyl-substituted benzoxazole was also compatible with standard conditions.

Identifiers

PMID40959297
PMCPMC12435190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.